Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below |
| WB | See 3 publications below |
| IHC | See 1 publications below |
| IF | See 1 publications below |
| IP | See 1 publications below |
Product Information
20547-1-AP targets KANK1 in WB, IHC, IF, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | Peptide 相同性解析による交差性が予測される生物種 |
| Full Name | KN motif and ankyrin repeat domains 1 |
| Calculated molecular weight | 147 kDa |
| GenBank accession number | NM_015158 |
| Gene Symbol | KANK1 |
| Gene ID (NCBI) | 23189 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q14678 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
KANK1, also named as ANKRD15, KANK and KIAA0172, is a potential tumor suppressor for renal cell carcinoma. The antibody is specific to KANK1.
Publications
| Species | Application | Title |
|---|---|---|
Oxid Med Cell Longev Identification and Characterization of the Roles of circCASP9 in Gastric Cancer Based on a circRNA-miRNA-mRNA Regulatory Network. | ||
J Biol Chem Nephrotic syndrome-associated mutation of KANK2 induces pathologic binding competition with physiological interactor KIF21A. | ||
Cell Death Dis TRAIP modulates the IGFBP3/AKT pathway to enhance the invasion and proliferation of osteosarcoma by promoting KANK1 degradation.
| ||